Fresenius Kabi Pharma Portugal, Lda. secures contract for Acquisition Of S Diallise From Lab Fresenius Medical Care, For Ulsasi, For The Year 2026

Portugal, Feb. 2 -- Portugal based Fresenius Kabi Pharma Portugal, Lda. has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of S Diallise From Lab Fresenius Medical Care, For Ulsasi, For The Year 2026. The value of the contract is worth 13799200 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....